FDA Approves the First mRNA Flu Vaccine

The shot, made by Moderna, will be available for this year's upcoming flu season.

The U.S. Food and Drug Administration has approved a new mRNA-based seasonal flu vaccine for people 50 and older, Moderna said this week.

The Food and Drug Administration on Wednesday approved the first mRNA-based influenza vaccine, marking a milestone for the technology, which was first widely used during the COVID-19 pandemic. The vaccine, developed by Moderna, is approved for adults ages 50 to 64 and those 65 and older, who face the highest risk of se

The agency granted approval to Moderna’s vaccine for adults ages 50 to 64 and accelerated approval for those 65 and older with a commitment to further study the shot in older adults.

The Food and Drug Administration (FDA) late Wednesday approved the nation’s first mRNA flu vaccine, manufactured by drugmaker Moderna.  The agency approved the shot for two separate age groups; people age 50 to 64, and for 65 years and older. Moderna said it will conduct a postmarket clinical trial to confirm the effec

FDA Approves First mRNA Flu Vaccine For Older Adults  Forbes

FDA approves first mRNA-based flu vaccine  CNN